跳至主要内容
临床试验/NCT04422223
NCT04422223招募中不适用

Copenhagen Liver Cohort Study: Disease Characteristics, Outcomes and Rehabilitation in Liver Cirrhosis - A Prospective Cohort Study

Copenhagen University Hospital, Hvidovre1 个研究点 分布在 1 个国家目标入组 550 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
550
试验地点
1
主要终点
Improve risk of decompensation in cirrhosis

研究概览

简要总结

A population based incidence cohort will enroll patients newly diagnosed with cirrhosis to investigate disease characteristics and outcomes, explore mechanisms predicting early death and hospital admission, and assess new monitoring tools in treatment and prevention of cirrhosis.

详细描述

INTRODUCTION In Denmark the incidence of liver cirrhosis is increasing. From 1996 to 2005 the number of hospital admissions due to liver cirrhosis rose with 2,500 extra admissions per year. Patients who are readmitted to the hospital have a higher 90 days mortality than those who avoid readmission.

Liver cirrhosis in Denmark is caused by a wide use of alcohol and a population increasing in age and BMI.

The course of cirrhosis depends on etiology, age and nutritional status, as well as social factors such as personal network, employment and economy. Interventional studies on many of these mechanisms are still unexplored.

Cirrhosis is related to decreased quality of life and affects patients and relatives both emotional and socioeconomically.

The Gastro Unit, Amager Hvidovre Hospital has a catchment area of 550,000 citizens in South and West of Copenhagen. The Gastro Unit diagnoses app. 140 people with liver cirrhosis yearly.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical suspicion of cirrhosis supported by biochemistry and ultrasound or other imaging techniques.
  • Cirrhosis of any etiology
  • Informed written consent

排除标准

  • People where the diagnosis of liver cirrhosis is questioned with reasonable doubt or the diagnosis of liver cirrhosis is disproved by histology or relevant imaging.
  • Withdrawal of informed consent or no informed consent.
  • Persons eligible for inclusion where the investigational program is delayed or not initiated within six months after the diagnosis of suspected cirrhosis.

结局指标

主要结局

Improve risk of decompensation in cirrhosis

时间窗: 5 years

time to development of decompensation

Survival

时间窗: 5 years

Time from diagnosis to death or liver transplantation

次要结局

  • Risk prediction by Short Physical Performance Battery(5 years)
  • Social impact of cirrhosis(5 years)
  • Characterization of patients(5 years)
  • Life space Assessment(5 years)

研究者

发起方
Copenhagen University Hospital, Hvidovre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nina Kimer

MD, PhD

Copenhagen University Hospital, Hvidovre

研究点 (1)

Loading locations...

相似试验